# Jasper Therapeutics, Inc.: Form 8-K/A, filed Sep 29, 2021

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K/A
- Filed: 2021-09-29
- Accepted by EDGAR: Sep 29, 2021, 16:46 ET
- Period: 2021-09-24
- Accession: 0001213900-21-050602
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390021050602/ea147933-8ka1_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390021050602/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 5.05: Item not in the standard list
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390021050602/ea147933-8ka1_jasper.htm

Filed Sep 29, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-050602. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.